Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvirin (2010/2011) Safety and Immunogenicity in Adults and Elderly
NCT01161264Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2010
- Primary completion
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza A virus hemagglutinin antigen (A/Uruguay/716/2007 H3N2) in seasonal influenza, sponsored by Novartis. Started Jul 2010; status: completed.
02
Drugs
Influenza A virus hemagglutinin antigen (A/Uruguay/716/2007 H3N2)
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on NCT01161264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01161264.